iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,456 shares of the financial services provider’s stock after selling 402 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in iShares Biotechnology ETF were worth $1,847,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at $27,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the second quarter worth about $31,000. Pacifica Partners Inc. lifted its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares in the last quarter. YHB Investment Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $37,000. Finally, Mather Group LLC. acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $57,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 1.6 %

Shares of IBB stock opened at $145.58 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The firm’s 50 day moving average price is $145.81 and its two-hundred day moving average price is $138.68.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.